PKC delta anticorps (AA 298-326) (FITC)
Aperçu rapide pour PKC delta anticorps (AA 298-326) (FITC) (ABIN1926608)
Antigène
Voir toutes PKC delta (PKCd) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 298-326
-
Specificité
- This PKC delta antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 298-326 amino acids from the N-terminal region of human PKC delta.
-
Purification
- Affinity purified
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: ELISA, IHC, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Date de péremption
- 6 months
-
-
- PKC delta (PKCd) (Protein Kinase C, delta (PKCd))
-
Autre désignation
- PRKCD / PKC-Delta
-
Sujet
-
Name/Gene ID: PRKCD
Subfamily: PKC
Family: Protein Kinase
Synonyms: PRKCD, MAY1, NPKC-delta, PKCD, Protein kinase C delta type, Protein kinase C delta VIII, Protein kinase C, delta, Pkcdelta, PKC delta, Protein kinase c delta, Tyrosine-protein kinase PRKCD -
ID gène
- 5580
-
Pathways
- Interferon-gamma Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Regulation of Actin Filament Polymerization, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Dicarboxylic Acid Transport, Positive Regulation of Response to DNA Damage Stimulus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, Lipid Metabolism
Antigène
-